Lineage Cell Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-23.6M | $-23.9M | $340.0K | $3.5M |
| FY2022 | $1.1M | $646.0K | $413.0K | $4.3M |
| FY2023 | $-28.6M | $-29.2M | $674.0K | $4.6M |
| FY2024 | $-23.1M | $-23.7M | $565.0K | $5.1M |
| FY2025 | $-18.9M | $-19.4M | $522.0K | $4.8M |